Price $4.23 |
Market Cap
59.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
17.2
|
P/B
4.38
|
P/S
0.3
|
Dividend %
-
|
|
P/CF
86.1
|
P/FCF
17.9
|
Op. Cash Flow
4.4K
|
FCF
0.2
|
|
Op. Margin
3.40%
|
Net Margin
1.90%
|
ROE
28.40%
|
ROI
49.80%
|
|
ROA
8.00%
|
EPS Growth
-1.00%
|
Current Ratio
1.5
|
Debt/Equity
62.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Veru Inc (VERU) | $2.32 | - | - | 85.7M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $1.46 | - | - | 42.8M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.64 | - | - | 24.3M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.81 | - | - | 4.6M | Strong Buy |
| Misonix, Inc. (MSON) | $10.20 | - | - | 91.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
